Abstract:AIM: To map the intellectual structure, temporal evolution, research hotspots, and emerging frontiers in the field of retinal biomarkers for schizophrenia. METHODS: The Web of Science Core Collection was searched for English-language records published from January 1, 1900 to April 7, 2026 using terms related to schizophrenia-spectrum disorders and retinal imaging or electrophysiological measures. After relevance screening, 305 of 529 retrieved records were included. Microsoft Excel 2019 and CiteSpace 6.4.R1 software were adopted to analyze annual publication trends, institutional and author collaboration networks, keyword co-occurrence, keyword clustering, and burst terms. RESULTS: The annual publication volume in this field showed an overall increasing trend. The University of Rochester and the Harvard system formed two highly productive collaborative clusters. Steven M. Silverstein was the most prolific author and a central connector. Research contents mainly focus on retinal structural abnormalities, visual electrophysiological disorders, dopaminergic dysfunction, retinal microvascular abnormalities as well as artificial intelligence and multimodal integration, which jointly confirm that the retina can act as a non-invasive window for evaluating pathological changes in the central nervous system. CONCLUSION: Research on retinal biomarkers of schizophrenia has shifted from descriptive functional observation to mechanism-oriented multimodal comprehensive research. Future work should prioritize rigorous confounder control, standardized optical coherence tomography/optical coherence tomography angiography/electroretinography protocols, large longitudinal cohorts, and externally validated artificial intelligence models for clinical translation.